efectos secundarios de la l-carnitina - efectos, secundarios, deficiencia Contraindicaciones y efectos secundarios de
Description
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats
The manufacturer discontinued both formulations in 2008 for business reasons, and a 2013 Federal Register determination confirmed the withdrawal was not for reasons of safety or effectiveness
P507 Segura Mestanza A
